Unity Software Insider Sold Shares Worth $4,380,000, According to a Recent SEC Filing-June 2024-www.financetom.com

Unity Software Insider Sold Shares Worth $4,380,000, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Unity Software Insider Sold Shares Worth $4,380,000, According to a Recent SEC Filing

Nov 19, 2024 9:14 PM

02:51 PM EST, 11/18/2024 (MT Newswires) -- Tomer Bar-Zeev, Director, on November 15, 2024, sold 250,000 shares in Unity Software ( U ) for $4,380,000. Following the Form 4 filing with the SEC, Bar-Zeev has control over a total of 5,425,796 shares of the company, with 1,177,650 shares held directly and 4,248,146 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1810806/000181080624000234/xslF345X05/wk-form4_1731959223.xml

Price: 17.95, Change: +0.61, Percent Change: +3.49

Previous page： Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell Next page： Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell

Oct 21, 2024

09:08 AM EDT, 10/21/2024 (MT Newswires) -- Regenxbio ( RGNX ) reported Monday a 97% reduction in anti-VEGF injections at nine months in a Phase II study of ABBV-RGX-314 for wet age-related macular degeneration, or AMD. In the subretinal treatment of the second eye, 78% of patients remained injection-free, the company said. Visual acuity and retinal thickness were maintained, with...

Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing

Oct 21, 2024

08:45 AM EDT, 10/21/2024 (MT Newswires) -- Elisabet de los Pinos, Director, President and Chief Executive Officer, on October 18, 2024, sold 24,992 shares in Aura Biosciences ( AURA ) for $300,839. Following the Form 4 filing with the SEC, Elisabet de los Pinos has control over a total of 461,259 shares of the company, with 329,847 shares held directly...

Nigeria blocks Shell's asset sale in the Niger Delta

Oct 21, 2024

ABUJA, Oct 21 (Reuters) - Nigeria has blocked the sale of Shell's entire onshore and shallow-water oil and gas assets in the Niger Delta, the country's upstream regulator said on Monday, roughly 10 months after the deal was announced. In a speech at an event in the capital Abuja, Nigerian Upstream Petroleum Regulatory Commission (NUPRC) CEO Gbenga Komolafe said the...

Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business

Oct 21, 2024

Sanofi SA ( SNY ) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to potentially sell and purchase a 50% controlling stake in Opella, Sanofi’s consumer health unit. The new step in Opella’s journey paves the way for creating a standalone player in consumer healthcare while supporting Sanofi’s strategy and increased focus on innovative...